Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abeona therapeutics
alnylam pharmaceuticals
2
×
amgen
2
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
2
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicare
national
national blog main
national top stories
new york blog main
new york top stories
novartis
2
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
2
×
wisconsin blog main
wisconsin top stories
accent therapeutics
achaogen
achilles therapeutics
affordable care act
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alopecia areata
What
bio
roundup
advantages
alzheimer’s
bar
brings
congress
democrats
divided
drug
elections
expect
fallout
gamble
losses
market
medco’s
midterm
mover
new
panel
patients
payers
physicians
plan
plenty
political
postpartum
pricing
search
sets
stake
terms
took
type
ubiome
undone
vertex’s
week’s
wins
Language
unset
Current search:
novartis
×
amgen
×
" texas top stories "
×
" clinical trials "
×
" alnylam pharmaceuticals "
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel